A recent diabetes discovery has been reported involving the transplantation of pig cells to treat diabetes. Since the year 2000, expert Dr. David White has been the Novartis/Stiller Professor of Xenotransplantation at the University of Western Ontario, investigating xenotransplantation procedures.
He is also the principal researcher for Canada based biotechnology Research Company . Together with the company, Dr. White spoke of a new development in the long road to reversing diabetes. He reportedly said: “The big breakthrough that we made was to discover that if you use Sertoli cells from adult pigs as opposed to what everybody else in the field has been doing – using it from sexually immature baby pigs, we get very much greater protection.”
Dr. White, who has a Cambridge University background, has marked significant progress using Sertoli cells, including the ability to: “completely suppress the immune response to pig insulin-producing cells.” He concluded: “After the transplants were completed, these insulin-producing cells will survive, and will protect the rats against diabetes.”
Cell transplantation is often discarded as a procedure on account of rejection of the cells by human test subjects. Whether this will remain so in the future remains to be seen.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…